Instruments, Equipment & Technology
|3 min read
ACLA Applauds Introduction of RESULTS Act to Safeguard Seniors’ Access to Critical Diagnostic Tests
Association relaunches ‘Stop Lab Cuts’ campaign to push for long-term Medicare payment reform
|4 min read
Emerging Technologies Guide: Fall 2025
Recent new and emerging technologies in the field of laboratory medicine from the 2025 September Pathogen Detection & Infectious Disease issue of Today's Clinical Lab
|2 min read
With Release of Aperture, Proscia Brings Clinical Labs Closer to Drug Discovery
AI analysis of pathology results could result in new revenue streams for laboratories
|2 min read
'Reemerging Threats, Reimagined Strategies'
The Today's Clinical Lab 2025 Pathogen Detection & Infectious Disease print issue features smarter diagnostics, reemerging threats, and lab-driven strategies for tackling sepsis, measles, and C. difficile infections
|4 min read
How Analyte Specific Reagents Support Quality in Research and Diagnostic Labs
Designed for regulated use, ASR antibodies enable reproducible results and reliable test performanceSponsored by
|4 min read
Challenges and Advances in Sepsis Detection
FDA-approved tests like Intellisep and TriVerity™ demonstrate potential for early sepsis diagnosis
|3 min read
Mount Sinai Researchers Use AI and Lab Tests to Predict Genetic Disease Risk
AI model uses common data to gauge risk from rare genetic variants
|1 min read
Reimagining Immunoassay Testing: The Case for Dry Reagent Systems
Explore how dry reagent immunoassays can reduce waste, simplify workflows, and support high-throughput lab efficiency without compromising accuracySponsored by
|1 min read
Bio-Rad Expands Range of StarBright Dyes to Enhance Panel Design Capabilities for Spectral Flow Cytometry
New range of StarBright™ dyes developed specifically for spectral flow cytometry provide greater flexibility in immunology research
Updated |2 min read
AliveDx's MosaiQ® Platform Registered with FDA as Class II 510(k) Exempt, Enabling US Labs to Adopt High-Throughput Automated Immunoassay Testing
MosaiQ is a next-gen immunoassay platform delivering automated, multiplexed testing and actionable insights for complex conditions
|3 min read
New Single-Tier Lyme Disease Test Shows Over 90 Percent Sensitivity in Early Diagnosis
Unlike standard two-tier protocols, the assay uses a dual-antigen binding approach to improve early detection accuracy and may offer a more efficient workflow for clinical labs
|3 min read
